Search

everythinglearnresearchcommunity

for

Search:↓

Ritlecitinib may help treat alopecia areata by protecting hair follicles.

Some medications and supplements can cause serious side effects, including hair loss, heart rhythm problems, liver injury, and other health issues.

Oral 5-alpha-reductase inhibitors for hair loss don't increase heart risk.

Imatinib mesylate can cause skin lightening, especially in Chinese patients, due to its effect on pigment production.

New compounds show promise for treating benign prostate hyperplasia with fewer side effects.

CTP-543 is generally safe for treating alopecia areata.

Minoxidil reduces lysine hydroxylase in skin cells.

5α-reductase inhibitors, like Finasteride and Dutasteride, help manage benign prostatic hyperplasia.

A man developed oral hairy leukoplakia while on baricitinib, a medication for alopecia and arthritis, and doctors should watch for such side effects.

Curcumin, EGCG, barringtozenol, and finasteride are effective VEGFR inhibitors.

Finasteride blocks progesterone production in specific tumor cells, potentially causing side effects.

5α-Reductase inhibitors can negatively impact sexual function.

Brepocitinib 30mg is most effective for moderate-to-severe alopecia areata, but ritlecitinib 50mg may offer a better balance of safety and effectiveness.

Ritlecitinib is generally safe for long-term use, with mostly mild side effects.

Finasteride reduces movement issues in Parkinson's disease rats.

Cadd4 effectively reduces cholesterol levels without side effects.

Finasteride helps treat hair loss and prostate enlargement by blocking a specific enzyme.

Securinine and ajmaline may effectively treat liver cancer, with securinine being less toxic to normal cells.

Minoxidil analogs can be improved for hair growth inhibition by modifying specific parts of their structure.

Ritlecitinib effectively reduces hair loss in JAK inhibitor-naïve alopecia areata patients.

JAK inhibitors effectively treat skin conditions and topical forms are safer.

Ruxolitinib treatment may cause eyelash growth.

Tofacitinib may help treat Lichen Planopilaris, but more research is needed.

JAK inhibitors show promise for treating skin conditions like eczema, hair loss, and psoriasis.

Compounds 4, 4b, and 4c effectively inhibit an enzyme linked to testosterone conversion without significant toxicity.

Different types of cells in the eye express specific keratins at various stages of development.

JAK inhibitors offer new hope for treating severe alopecia areata.

The new compounds moderately block a specific enzyme and strongly counteract a male hormone, suggesting potential for treating certain male-related health conditions.

Finasteride is high-risk for cognitive disorders, while Carbidopa/Levodopa, Topiramate, and Clonazepam are moderate-risk.